FDA Inspection
The Methodist Hospital Research InstituteThe Methodist Hospital Research Institute – FDA Inspection, Feb 13, 2026
Record Details
This FDA Inspection record concerns The Methodist Hospital Research Institute, with an inspection on February 13, 2026, issued by the Dallas District Office, covering human drugs.
- Inspection Date
- February 13, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 3e71de24-7956-43b5-a39a-e8daab16f997
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1302066
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 212.20(a)Oversight of production operations
- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.30(b)Equipment procedures
- 21 CFR 212.50Adequate controls (general)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Methodist Hospital Research Institute
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 19, 2024 | VAI | Dallas District Office | Generic Drug Evaluation |
| November 2, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Methodist Hospital Research Institute
- FDA Inspection 1244364 - 2024-07-19
- FDA Inspection 1070966 - 2018-11-02
- FDA Inspection 892810 - 2014-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.